October 18, 2018

Oral DS107 found to reverse the molecular signature of moderate to severe atopic dermatitis patients in a phase 2 trial

Dublin, Ireland, October 18th 2018 – DS Biopharma (DS), a privately held biopharmaceutical company, today announced that oral treatment with DS107 reversed the molecular signature of […]
October 3, 2018

DS Biopharma announces positive top-line phase 2b trial results for DS107 as a topical treatment for mild to moderate atopic dermatitis

DS Biopharma announces positive top-line phase 2b trial results for DS107 as a topical treatment for mild to moderate atopic dermatitis Dublin, Ireland, October 3rd 2018 […]
December 11, 2017

DS Biopharma receives a patent allowance for DS109 in the US

Dublin, Ireland, December 11th, 2017 – DS Biopharma (DS), a clinical stage biopharmaceutical company, today announced receipt of allowance for a patent application in the United […]
May 8, 2017

DS Biopharma appoints Professor Brendan Buckley as Non-Executive Director

Dublin, Ireland, May 8th, 2017 – DS Biopharma (DS), a clinical stage biopharmaceutical company, today announced the appointment of Professor Brendan Buckley as a non-executive director […]
April 13, 2017

DS Biopharma receives a patent allowance for Oral DS107 in the US

Dublin, Ireland, April 13th, 2017 – DS Biopharma (DS), a clinical stage biopharmaceutical company, today announced receipt of allowance for a patent application in the United […]
February 7, 2017

DS Biopharma appoints Jane Hollingsworth as Non-Executive Director

Dublin, Ireland, February 7, 2017 – DS Biopharma (DS), a clinical stage biopharmaceutical company, today announced the appointment of Jane Hollingsworth as a non-executive director to […]
January 6, 2017

DS Biopharma (DS) announces that recruitment has begun in two separate Phase 2b atopic dermatitis studies with lead compound DS107 as well as the successful completion of a Phase 1 trial for follow on compound DS109

Dublin, Ireland, 6th January, 2017: DS Biopharma (DS), a privately held, clinical stage, pharmaceutical drug discovery and development company, today announced that recruitment has begun in […]
November 28, 2016

DS Biopharma to present at Piper Jaffray 28th Annual Healthcare Conference

Dublin, Ireland, 28th November, 2016: DS Biopharma (DS), a privately held drug discovery and development company, today announced that it will present an overview of the […]
September 29, 2016

DS Biopharma will today present data on a Phase IIa study at the European Academy of Dermatology and Venereology (EADV) Congress

Dublin, Ireland, 29th September 2016: DS Biopharma (DS) will today present data on their Phase IIa study with DS107 for the treatment of atopic dermatitis at […]
September 15, 2016

DS Biopharma announces the appointment of Dr. Markus Weissbach as Chief Operating Officer

Dublin, Ireland, 14th September 2016: DS Biopharma (DS) today announced the appointment of Dr. Markus Weissbach (MD, PhD) to Chief Operating Officer. Markus has been Medical […]
August 23, 2016

DS Biopharma (DS) Announces Spin-Out Company Focused on Fibrotic Conditions and Pulmonary Disorders

Dublin, Ireland, 22 August 2016: DS Biopharma (DS), a privately held drug discovery and development company with industry-leading expertise in lipid science, today announces the launch […]
January 7, 2016

DS Biopharma announces positive top-line Phase IIa trial results for DS107 as an oral treatment for moderate to severe atopic dermatitis

Dublin, Ireland, January 7th, 2016 – DS Biopharma (DS), a privately held biopharmaceutical company, today announced positive top-line results from a Phase IIa clinical trial of […]
September 25, 2015

DS Biopharma appoints Leopoldo Zambeletti as Non-Executive Director

Dublin, Ireland, September 25, 2015 – DS Biopharma, a privately held biopharmaceutical company, today announced the appointment of Leopoldo Zambeletti as a Non-Executive Director to the […]
May 14, 2015

DS Biopharma to present at UBS Global Healthcare Conference

Dublin, Ireland, 14 May, 2015: DS Biopharma (DS), a privately held drug discovery and development company, today announced that it will present at the UBS Global […]
March 20, 2015

DS Biopharma (DS) presents late-breaking news abstract on DS107 at the American Association of Dermatology (AAD) Annual Meeting

DS Biopharma (DS) presents late-breaking news abstract on DS107 at the American Association of Dermatology (AAD) Annual Meeting; “The effective and safe use of DS107 cream […]